Brochure | September 3, 2020

A New Aseptic Solution For The Filling Of Complex Parenterals In Powder, Liquid Or Suspension Form

Evonik Pharma Image 2

Traditional filling lines lack the necessary versatility to address the growing number of complex and personalized parenteral drug products that are now being brought to market. Evonik has recently qualified a new modular aseptic filling platform that will efficiently fill drug products in powder, liquid, suspension or combination form.

Many parenteral products that utilize advanced formulation technologies to deliver complex small molecules, peptides, proteins, and nucleic acids can face a number of stability, sterility, scalability and other cGMP manufacturing challenges. As one example, while terminal sterilization methods such as gamma irradiation are highly effective and reliable, this process may degrade the active pharmaceutical ingredient. This inherent incompatibility has necessitated the creation of specialized solutions for the aseptic manufacturing and filling of these parenteral drug products. 

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: